Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

2.38
Delayed Data
As of 4:00pm ET
 +0.01 / +0.42%
Today’s Change
2.20
Today|||52-Week Range
5.02
-32.77%
Year-to-Date
No recent news for Celldex Therapeutics Inc.

Today’s Trading

Previous close2.37
Today’s open2.37
Day’s range2.34 - 2.44
Volume972,555
Average volume (3 months)1,875,128
Market cap$296.5M
Dividend yield--
Data as of 4:00pm ET, 07/20/2017

Growth & Valuation

Earnings growth (last year)+3.05%
Earnings growth (this year)+12.73%
Earnings growth (next 5 years)--
Revenue growth (last year)+23.83%
P/E ratioNM
Price/Sales52.96
Price/Book1.08

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc+0.11+1.37%
QTNTQuotient Ltd-0.09-1.44%
OXFDOxford Immunotec Glo...-0.24-1.44%
TRIBTrinity Biotech PLC+0.13+2.25%
Data as of 4:00pm ET, 07/20/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$6.8M
Annual profit (last year)-$128.5M
Net profit margin-1,894.05%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
Chief Financial Officer &
Senior Vice President
Sam Martin
Corporate headquarters
Hampton, New Jersey

Forecasts